The gut microbiota is closely associated with the progression of colorectal cancer (CRC) in
which Fusobacterium nucleatum (F. nucleatum) was found to induce cancer resistance to …

Simple Summary Colorectal cancer (CRC) is the third most common malignancy and the
second most deadly cancer worldwide. Recent studies have uncovered the close …

Background Accumulating evidence links colorectal cancer (CRC) with the intestinal
microbiota. However, the disturbance of intestinal microbiota and the role of Fusobacterium …

The tumor microenvironment has recently been shown to play decisive roles in
chemotherapeutic response. In this issue of Cell, Yu et al. add to these findings by …

BACKGROUND Fusobacterium nucleatum (F. nucleatum) has long been known to cause
opportunistic infections and has recently been implicated in colorectal cancer (CRC), which …

Metastasis is the leading cause of death for colorectal cancer (CRC) patients, and the
spreading tumor cells adhesion to endothelial cells is a critical step for extravasation and …

Fusobacterium nucleatum is implicated in accelerating colorectal cancer (CRC) and is found
within metastatic CRC cells in patient biopsies. Here, we found that bacterial invasion of …

Colorectal cancer (CRC) is a common clinical malignant tumor and closely related to
intestinal microbiome disorders. Especially, Fusobacterium nucleatum (F. nucleatum) is one …

Fusobacterium nucleatum is a critical microbe that contributes to colorectal cancer
progression and chemoresistance. However, whether and how F. nucleatum regulates …

Colorectal cancer (CRC) is a common cancer worldwide with complex etiology.
Fusobacterium nucleatum (F. nucleatum), an oral symbiotic bacterium, has been linked with …